Tissue Repair (TRP.AX) Stock Price

Tissue Repair Price

CLOSED
0.09
​
Market closed

Revenue has compounded at 291.3% per year over the past 6 years to 559,702.00 AUD. Tissue Repair's net margin stands at -958.0%, up from -3,977.2% several years earlier.

Tissue Repair stock price

Access this data via the Eulerpool API

Tissue Repair business model & stock analysis

Tissue Repair Ltd. is a clinical stage bio pharmaceutical company. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-11-18. The firm is engaged in developing advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures, with the potential for further development of related technologies. The firm is in the final stages of completing its Phase II program for its chronic wound product, TR-987. The company also concluded Phase IIB trials on its proprietary molecule, Glucoprime. The firm is also focused on commercialization of its cosmeceutical post-procedure gel product, TR Pro+, which is used in certain minimally invasive cosmetic procedures.

Frequently asked questions about Tissue Repair

5 analysts currently rate the Tissue Repair stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Tissue Repair share trades at 0.05 EUR (0.09 AUD).

The revenue of Tissue Repair is 559,702.00 AUD. This figure is based on current financial data and reflects the company's business performance.

The profit of Tissue Repair is -5.36 M AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Tissue Repair is currently -0.96. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Tissue Repair stock.

The price-to-sales ratio (P/S) of Tissue Repair is currently 9.18. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Tissue Repair stock.

The Eulerpool Quality Score for Tissue Repair is 3/10.

The ISIN of Tissue Repair is AU0000180887. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Tissue Repair is TRP.AX. The ticker symbol is used to trade Tissue Repair shares on the stock exchange.

Fair ValueTerminal
0.07 AUD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Australia
Currency
AUD
Initial public offering
Nov 18, 2021
ISIN
AU0000180887
Cusip
Q9054T104
Market capitalization
5.14 M AUDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.59
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-61.11 %
Last updated Oct 8, 2026, 9:50 PM

Tissue Repair Peer Group

Tissue Repair FIGI

TRP:AU · BBG012XR9V64TRP:AT · BBG012XR9V73TRP:AH · BBG012XR9VC7